{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:22:37Z","timestamp":1792426957479,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1038\/s41584-023-01009-0","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T08:01:32Z","timestamp":1693987292000},"page":"627-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Innate immune memory in inflammatory arthritis"],"prefix":"10.1038","volume":"19","author":[{"given":"Maxime M.","family":"Jeljeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3708-2965","authenticated-orcid":false,"given":"Iannis E.","family":"Adamopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"1009_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.iy.09.040191.001205","volume":"9","author":"ES Vitetta","year":"1991","unstructured":"Vitetta, E. S. et al. Memory B and T cells. Annu. Rev. Immunol. 9, 193\u2013217 (1991).","journal-title":"Annu. Rev. Immunol."},{"key":"1009_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","volume":"9","author":"MG Netea","year":"2011","unstructured":"Netea, M. G., Quintin, J. & van der Meer, J. W. Trained immunity: a memory for innate host defense. Cell Host Microbe 9, 355\u2013361 (2011).","journal-title":"Cell Host Microbe"},{"key":"1009_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nri.2015.9","volume":"16","author":"A Cerwenka","year":"2016","unstructured":"Cerwenka, A. & Lanier, L. L. Natural killer cell memory in infection, inflammation and cancer. Nat. Rev. Immunol. 16, 112\u2013123 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1009_CR4","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).","journal-title":"Science"},{"key":"1009_CR5","doi-asserted-by":"publisher","first-page":"110184","DOI":"10.1016\/j.celrep.2021.110184","volume":"38","author":"P Brandi","year":"2022","unstructured":"Brandi, P. et al. Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections. Cell Rep. 38, 110184 (2022).","journal-title":"Cell Rep."},{"key":"1009_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","volume":"181","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell 181, 969\u2013977 (2020).","journal-title":"Cell"},{"key":"1009_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","volume":"183","author":"L Kalafati","year":"2020","unstructured":"Kalafati, L. et al. Innate immune training of granulopoiesis promotes anti-tumor activity. Cell 183, 771\u2013785.e712 (2020).","journal-title":"Cell"},{"key":"1009_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28407-4","volume":"13","author":"AE Geller","year":"2022","unstructured":"Geller, A. E. et al. The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression. Nat. Commun. 13, 759 (2022).","journal-title":"Nat. Commun."},{"key":"1009_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","volume":"172","author":"S Bekkering","year":"2018","unstructured":"Bekkering, S. et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell 172, 135\u2013146.e139 (2018).","journal-title":"Cell"},{"key":"1009_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","volume":"382","author":"F Goldblatt","year":"2013","unstructured":"Goldblatt, F. & O\u2019Neill, S. G. Clinical aspects of autoimmune rheumatic diseases. Lancet 382, 797\u2013808 (2013).","journal-title":"Lancet"},{"key":"1009_CR11","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","volume":"125","author":"DD Chaplin","year":"2010","unstructured":"Chaplin, D. D. Overview of the immune response. J. Allergy Clin. Immunol. 125, S3\u2013S23 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1009_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775\u2013787 (2008).","journal-title":"Cell"},{"key":"1009_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri.2017.24","volume":"17","author":"DJ Rawlings","year":"2017","unstructured":"Rawlings, D. J., Metzler, G., Wray-Dutra, M. & Jackson, S. W. Altered B cell signalling in autoimmunity. Nat. Rev. Immunol. 17, 421\u2013436 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1009_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41584-021-00601-6","volume":"17","author":"P Maschmeyer","year":"2021","unstructured":"Maschmeyer, P. et al. Immunological memory in rheumatic inflammation \u2014 a roadblock to tolerance induction. Nat. Rev. Rheumatol. 17, 291\u2013305 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1009_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/ard.62.4.291","volume":"62","author":"AH Gerards","year":"2003","unstructured":"Gerards, A. H. et al. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial. Ann. Rheum. Dis. 62, 291\u2013296 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR16","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/rheumatology\/keh155","volume":"43","author":"DE Yocum","year":"2004","unstructured":"Yocum, D. E. et al. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology 43, 992\u2013999 (2004).","journal-title":"Rheumatology"},{"key":"1009_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41927-019-0058-7","volume":"3","author":"AA Mangoni","year":"2019","unstructured":"Mangoni, A. A. et al. Relapse rates after elective discontinuation of anti-TNF therapy in rheumatoid arthritis: a meta-analysis and review of literature. BMC Rheumatol. 3, 10 (2019).","journal-title":"BMC Rheumatol."},{"key":"1009_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/annrheumdis-2014-206439","volume":"75","author":"J Haschka","year":"2016","unstructured":"Haschka, J. et al. Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Ann. Rheum. Dis. 75, 45\u201351 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR19","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/art.10495","volume":"46","author":"J Moore","year":"2002","unstructured":"Moore, J. et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum. 46, 2301\u20132309 (2002).","journal-title":"Arthritis Rheum."},{"key":"1009_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10067-021-05931-0","volume":"41","author":"JC Jaime-P\u00e9rez","year":"2022","unstructured":"Jaime-P\u00e9rez, J. C. et al. Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort. Clin. Rheumatol. 41, 869\u2013876 (2022).","journal-title":"Clin. Rheumatol."},{"key":"1009_CR21","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/art.21219","volume":"52","author":"YK Teng","year":"2005","unstructured":"Teng, Y. K. et al. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum. 52, 2272\u20132276 (2005).","journal-title":"Arthritis Rheum."},{"key":"1009_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis, I. et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 172, 147\u2013161.e112 (2018).","journal-title":"Cell"},{"key":"1009_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann, E. et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172, 176\u2013190.e119 (2018).","journal-title":"Cell"},{"key":"1009_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts, R. J. W. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23, 89\u2013100.e105 (2018).","journal-title":"Cell Host Microbe"},{"key":"1009_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","volume":"172","author":"A Christ","year":"2018","unstructured":"Christ, A. et al. Western diet triggers NLRP3-dependent innate immune reprogramming. Cell 172, 162\u2013175 e114 (2018).","journal-title":"Cell"},{"key":"1009_CR26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41590-019-0402-5","volume":"20","author":"T Chavakis","year":"2019","unstructured":"Chavakis, T., Mitroulis, I. & Hajishengallis, G. Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat. Immunol. 20, 802\u2013811 (2019).","journal-title":"Nat. Immunol."},{"key":"1009_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrrheum.2009.278","volume":"6","author":"AN Theofilopoulos","year":"2010","unstructured":"Theofilopoulos, A. N. et al. Sensors of the innate immune system: their link to rheumatic diseases. Nat. Rev. Rheumatol. 6, 146\u2013156 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1009_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray, P. J. Macrophage polarization. Annu. Rev. Physiol. 79, 541\u2013566 (2017).","journal-title":"Annu. Rev. Physiol."},{"key":"1009_CR29","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204782","volume":"74","author":"IE Adamopoulos","year":"2015","unstructured":"Adamopoulos, I. E. et al. IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis. Ann. Rheum. Dis. 74, 1284\u20131292 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.4049\/jimmunol.1003986","volume":"187","author":"IE Adamopoulos","year":"2011","unstructured":"Adamopoulos, I. E. et al. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J. Immunol. 187, 951\u2013959 (2011).","journal-title":"J. Immunol."},{"key":"1009_CR31","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.4049\/jimmunol.1600383","volume":"197","author":"E Suzuki","year":"2016","unstructured":"Suzuki, E. et al. T cell-independent mechanisms associated with neutrophil extracellular trap formation and selective autophagy in IL-17A-mediated epidermal hyperplasia. J. Immunol. 197, 4403\u20134412 (2016).","journal-title":"J. Immunol."},{"key":"1009_CR32","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.cell.2022.03.043","volume":"185","author":"X Li","year":"2022","unstructured":"Li, X. et al. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell 185, 1709\u20131727.e1718 (2022).","journal-title":"Cell"},{"key":"1009_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2005.01.011","volume":"22","author":"MA Stark","year":"2005","unstructured":"Stark, M. A. et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22, 285\u2013294 (2005).","journal-title":"Immunity"},{"key":"1009_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.immuni.2018.01.009","volume":"48","author":"MR Mamedov","year":"2018","unstructured":"Mamedov, M. R. et al. A macrophage colony-stimulating-factor-producing \u03b3\u03b4 T cell subset prevents malarial parasitemic recurrence. Immunity 48, 350\u2013363.e357 (2018).","journal-title":"Immunity"},{"key":"1009_CR35","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/art.42124","volume":"74","author":"CT Nguyen","year":"2022","unstructured":"Nguyen, C. T. et al. Peripheral \u03b3\u03b4 T cells regulate neutrophil expansion and recruitment in experimental psoriatic arthritis. Arthritis Rheumatol. 74, 1524\u20131534 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1009_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07911-6","volume":"10","author":"K Venken","year":"2019","unstructured":"Venken, K. et al. ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in spondyloarthritis patients. Nat. Commun. 10, 9 (2019).","journal-title":"Nat. Commun."},{"key":"1009_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01771-2","volume":"8","author":"MH Al-Mossawi","year":"2017","unstructured":"Al-Mossawi, M. H. et al. Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. Nat. Commun. 8, 1510 (2017).","journal-title":"Nat. Commun."},{"key":"1009_CR38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191421","author":"C Louis","year":"2020","unstructured":"Louis, C. et al. NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20191421 (2020).","journal-title":"J. Exp. Med."},{"key":"1009_CR39","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1182\/blood-2011-11-391342","volume":"120","author":"KA Oduro Jr","year":"2012","unstructured":"Oduro, K. A. Jr et al. Myeloid skewing in murine autoimmune arthritis occurs in hematopoietic stem and primitive progenitor cells. Blood 120, 2203\u20132213 (2012).","journal-title":"Blood"},{"key":"1009_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.87","volume":"6","author":"TH Chen","year":"2015","unstructured":"Chen, T. H., Swarnkar, G., Mbalaviele, G. & Abu-Amer, Y. Myeloid lineage skewing due to exacerbated NF-\u03baB signaling facilitates osteopenia in Scurfy mice. Cell Death Dis. 6, e1723 (2015).","journal-title":"Cell Death Dis."},{"key":"1009_CR41","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/ard.2004.029751","volume":"64","author":"JJ Haringman","year":"2005","unstructured":"Haringman, J. J. et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann. Rheum. Dis. 64, 834\u2013838 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/path.4466","volume":"235","author":"B Soler Palacios","year":"2015","unstructured":"Soler Palacios, B. et al. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile. J. Pathol. 235, 515\u2013526 (2015).","journal-title":"J. Pathol."},{"key":"1009_CR43","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N","volume":"44","author":"KJ Katschke Jr.","year":"2001","unstructured":"Katschke, K. J. Jr. et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes\/macrophages in rheumatoid arthritis. Arthritis Rheum. 44, 1022\u20131032 (2001).","journal-title":"Arthritis Rheum."},{"key":"1009_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13075-015-0901-1","volume":"18","author":"P Lacerte","year":"2016","unstructured":"Lacerte, P. et al. Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists. Arthritis Res. Ther. 18, 10 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"1009_CR45","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/ard.2005.050963","volume":"65","author":"AW van Kuijk","year":"2006","unstructured":"van Kuijk, A. W., Reinders-Blankert, P., Smeets, T. J., Dijkmans, B. A. & Tak, P. P. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann. Rheum. Dis. 65, 1551\u20131557 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR46","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fimmu.2016.00512","volume":"7","author":"H Zhu","year":"2016","unstructured":"Zhu, H. et al. CD16+ monocyte subset was enriched and functionally exacerbated in driving T-cell activation and B-cell response in systemic lupus erythematosus. Front. Immunol. 7, 512 (2016).","journal-title":"Front. Immunol."},{"key":"1009_CR47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/rheumatology\/keh112","volume":"43","author":"AL Hepburn","year":"2004","unstructured":"Hepburn, A. L., Mason, J. C. & Davies, K. A. Expression of Fc\u03b3 and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology 43, 547\u2013554 (2004).","journal-title":"Rheumatology"},{"key":"1009_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1006\/clim.2001.5172","volume":"103","author":"CG Katsiari","year":"2002","unstructured":"Katsiari, C. G. et al. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus. Clin. Immunol. 103, 54\u201362 (2002).","journal-title":"Clin. Immunol."},{"key":"1009_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/08916934.2018.1494161","volume":"51","author":"S Mohammadi","year":"2018","unstructured":"Mohammadi, S., Memarian, A., Sedighi, S., Behnampour, N. & Yazdani, Y. Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: a crucial role for aryl hydrocarbon receptor. Autoimmunity 51, 199\u2013209 (2018).","journal-title":"Autoimmunity"},{"key":"1009_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/ard.59.4.283","volume":"59","author":"F Steinbach","year":"2000","unstructured":"Steinbach, F. et al. Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann. Rheum. Dis. 59, 283\u2013288 (2000).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/art.20780","volume":"52","author":"J Frosteg\u00e5rd","year":"2005","unstructured":"Frosteg\u00e5rd, J. et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum. 52, 192\u2013200 (2005).","journal-title":"Arthritis Rheum."},{"key":"1009_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1237","volume":"10","author":"T McGarry","year":"2021","unstructured":"McGarry, T. et al. Rheumatoid arthritis CD14+ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease. Clin. Transl. Immunol. 10, e1237 (2021).","journal-title":"Clin. Transl. Immunol."},{"key":"1009_CR53","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1002\/art.34544","volume":"64","author":"RA Gordon","year":"2012","unstructured":"Gordon, R. A., Grigoriev, G., Lee, A., Kalliolias, G. D. & Ivashkiv, L. B. The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor \u03b1 and counter-regulated by the synovial fluid microenvironment. Arthritis Rheum. 64, 3119\u20133128 (2012).","journal-title":"Arthritis Rheum."},{"key":"1009_CR54","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","volume":"31","author":"X Hu","year":"2009","unstructured":"Hu, X. & Ivashkiv, L. B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31, 539\u2013550 (2009).","journal-title":"Immunity"},{"key":"1009_CR55","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.immuni.2013.08.009","volume":"39","author":"Y Qiao","year":"2013","unstructured":"Qiao, Y. et al. Synergistic activation of inflammatory cytokine genes by interferon-\u03b3-induced chromatin remodeling and toll-like receptor signaling. Immunity 39, 454\u2013469 (2013).","journal-title":"Immunity"},{"key":"1009_CR56","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv, L. B. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 18, 545\u2013558 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1009_CR57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2020.10.011","volume":"54","author":"S Fanucchi","year":"2021","unstructured":"Fanucchi, S., Dominguez-Andres, J., Joosten, L. A. B., Netea, M. G. & Mhlanga, M. M. The intersection of epigenetics and metabolism in trained immunity. Immunity 54, 32\u201343 (2021).","journal-title":"Immunity"},{"key":"1009_CR58","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1009_CR59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"AK Jha","year":"2015","unstructured":"Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419\u2013430 (2015).","journal-title":"Immunity"},{"key":"1009_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.smim.2016.09.002","volume":"28","author":"RJ Arts","year":"2016","unstructured":"Arts, R. J., Joosten, L. A. & Netea, M. G. Immunometabolic circuits in trained immunity. Semin. Immunol. 28, 425\u2013430 (2016).","journal-title":"Semin. Immunol."},{"key":"1009_CR61","first-page":"739","volume":"27","author":"T McNearney","year":"2000","unstructured":"McNearney, T., Speegle, D., Lawand, N., Lisse, J. & Westlund, K. N. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J. Rheumatol. 27, 739\u2013745 (2000).","journal-title":"J. Rheumatol."},{"key":"1009_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097501","volume":"9","author":"S Kim","year":"2014","unstructured":"Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014).","journal-title":"PLoS One"},{"key":"1009_CR63","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/rheumatology\/kez378","volume":"59","author":"LC Rodgers","year":"2020","unstructured":"Rodgers, L. C. et al. The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretion. Rheumatology 59, 869\u2013878 (2020).","journal-title":"Rheumatology"},{"key":"1009_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223284","author":"A Meyer","year":"2023","unstructured":"Meyer, A. et al. Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells. Ann. Rheum. Dis. https:\/\/doi.org\/10.1136\/ard-2022-223284 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR65","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng, S. C. et al. mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).","journal-title":"Science"},{"key":"1009_CR66","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrrheum.2017.147","volume":"13","author":"E Ballestar","year":"2017","unstructured":"Ballestar, E. & Li, T. New insights into the epigenetics of inflammatory rheumatic diseases. Nat. Rev. Rheumatol. 13, 593\u2013605 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1009_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0179-4","volume":"8","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. et al. H3K4 tri-methylation breadth at transcription start sites impacts the transcriptome of systemic lupus erythematosus. Clin. Epigenetics 8, 14 (2016).","journal-title":"Clin. Epigenetics"},{"key":"1009_CR68","first-page":"158","volume":"28","author":"Y Dai","year":"2010","unstructured":"Dai, Y., Zhang, L., Hu, C. & Zhang, Y. Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Clin. Exp. Rheumatol. 28, 158\u2013168 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1009_CR69","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41423-018-0037-8","volume":"16","author":"W Wu","year":"2019","unstructured":"Wu, W. et al. Cystathionine-\u03b3-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis. Cell Mol. Immunol. 16, 694\u2013705 (2019).","journal-title":"Cell Mol. Immunol."},{"key":"1009_CR70","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI16153","volume":"111","author":"N Mishra","year":"2003","unstructured":"Mishra, N., Reilly, C. M., Brown, D. R., Ruiz, P. & Gilkeson, G. S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse. J. Clin. Invest. 111, 539\u2013552 (2003).","journal-title":"J. Clin. Invest."},{"key":"1009_CR71","doi-asserted-by":"publisher","first-page":"818070","DOI":"10.3389\/fimmu.2022.818070","volume":"13","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z. et al. Inhibition of histone H3 lysine-27 demethylase activity relieves rheumatoid arthritis symptoms via repression of IL6 transcription in macrophages. Front. Immunol. 13, 818070 (2022).","journal-title":"Front. Immunol."},{"key":"1009_CR72","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molimm.2017.01.009","volume":"83","author":"YC Lin","year":"2017","unstructured":"Lin, Y. C. et al. Tumor necrosis factor-\u03b1 inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification. Mol. Immunol. 83, 82\u201391 (2017).","journal-title":"Mol. Immunol."},{"key":"1009_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert, L. F. R. & MacRae, I. J. Regulation of microRNA function in animals. Nat. Rev. Mol. Cell Biol. 20, 21\u201337 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1009_CR74","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-018-0253-5","volume":"559","author":"JJ Seeley","year":"2018","unstructured":"Seeley, J. J. et al. Induction of innate immune memory via microRNA targeting of chromatin remodelling factors. Nature 559, 114\u2013119 (2018).","journal-title":"Nature"},{"key":"1009_CR75","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.1019536108","volume":"108","author":"M Kurowska-Stolarska","year":"2011","unstructured":"Kurowska-Stolarska, M. et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl Acad. Sci. USA 108, 11193\u201311198 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1009_CR76","doi-asserted-by":"publisher","first-page":"756825","DOI":"10.3389\/fimmu.2021.756825","volume":"12","author":"B Yang","year":"2021","unstructured":"Yang, B. et al. Decreased miR-4512 levels in monocytes and macrophages of individuals with systemic lupus erythematosus contribute to innate immune activation and neutrophils NETosis by targeting TLR4 and CXCL2. Front. Immunol. 12, 756825 (2021).","journal-title":"Front. Immunol."},{"key":"1009_CR77","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/annrheumdis-2019-215355","volume":"78","author":"J Rodr\u00edguez-Ubreva","year":"2019","unstructured":"Rodr\u00edguez-Ubreva, J. et al. Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis. Ann. Rheum. Dis. 78, 1505\u20131516 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR78","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13075-015-0748-5","volume":"17","author":"MC de Andres","year":"2015","unstructured":"de Andres, M. C. et al. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate. Arthritis Res. Ther. 17, 233 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"1009_CR79","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928\u2013942 (2019).","journal-title":"Nat. Immunol."},{"key":"1009_CR80","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295\u20131306 (2020).","journal-title":"Nat. Med."},{"key":"1009_CR81","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","volume":"131","author":"CV Rothlin","year":"2007","unstructured":"Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124\u20131136 (2007).","journal-title":"Cell"},{"key":"1009_CR82","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1016\/j.celrep.2020.02.101","volume":"30","author":"T Adomati","year":"2020","unstructured":"Adomati, T. et al. Dead cells induce innate anergy via Mertk after acute viral infection. Cell Rep. 30, 3671\u20133681.e3675 (2020).","journal-title":"Cell Rep."},{"key":"1009_CR83","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13075-019-1998-4","volume":"21","author":"HMY de Jong","year":"2019","unstructured":"de Jong, H. M. Y. et al. Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-\u03b1 inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial. Arthritis Res. Ther. 21, 208 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"1009_CR84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fimmu.2019.00003","volume":"10","author":"Y Degbo\u00e9","year":"2019","unstructured":"Degbo\u00e9, Y. et al. Polarization of rheumatoid macrophages by TNF targeting through an IL-10\/STAT3 mechanism. Front. Immunol. 10, 3 (2019).","journal-title":"Front. Immunol."},{"key":"1009_CR85","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/annrheumdis-2017-212537","volume":"77","author":"C Municio","year":"2018","unstructured":"Municio, C. et al. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism. Ann. Rheum. Dis. 77, 752\u2013759 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR86","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.immuni.2013.08.016","volume":"39","author":"M Xia","year":"2013","unstructured":"Xia, M. et al. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20. Immunity 39, 470\u2013481 (2013).","journal-title":"Immunity"},{"key":"1009_CR87","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","volume":"19","author":"M Tsukasaki","year":"2019","unstructured":"Tsukasaki, M. & Takayanagi, H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat. Rev. Immunol. 19, 626\u2013642 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1009_CR88","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrg1122","volume":"4","author":"SL Teitelbaum","year":"2003","unstructured":"Teitelbaum, S. L. & Ross, F. P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638\u2013649 (2003).","journal-title":"Nat. Rev. Genet."},{"key":"1009_CR89","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/stem.2625","volume":"35","author":"FA Fierro","year":"2017","unstructured":"Fierro, F. A., Nolta, J. A. & Adamopoulos, I. E. Concise review: stem cells in osteoimmunology. Stem Cell 35, 1461\u20131467 (2017).","journal-title":"Stem Cell"},{"key":"1009_CR90","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/path.1891","volume":"208","author":"IE Adamopoulos","year":"2006","unstructured":"Adamopoulos, I. E. et al. Synovial fluid macrophages are capable of osteoclast formation and resorption. J. Pathol. 208, 35\u201343 (2006).","journal-title":"J. Pathol."},{"key":"1009_CR91","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrrheum.2014.198","volume":"11","author":"IE Adamopoulos","year":"2015","unstructured":"Adamopoulos, I. E. & Mellins, E. D. Alternative pathways of osteoclastogenesis in inflammatory arthritis. Nat. Rev. Rheumatol. 11, 189\u2013194 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1009_CR92","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar2936","volume":"12","author":"IE Adamopoulos","year":"2010","unstructured":"Adamopoulos, I. E. et al. Interleukin-17A upregulates receptor activator of NF-\u03baB on osteoclast precursors. Arthritis Res. Ther. 12, R29 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"1009_CR93","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4049\/jimmunol.1401013","volume":"194","author":"HS Shin","year":"2015","unstructured":"Shin, H. S. et al. Crosstalk among IL-23 and DNAX activating protein of 12 kDa-dependent pathways promotes osteoclastogenesis. J. Immunol. 194, 316\u2013324 (2015).","journal-title":"J. Immunol."},{"key":"1009_CR94","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1073\/pnas.1010030108","volume":"108","author":"A Yarilina","year":"2011","unstructured":"Yarilina, A., Xu, K., Chen, J. & Ivashkiv, L. B. TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proc. Natl Acad. Sci. USA 108, 1573\u20131578 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1009_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/art.42478","author":"H Furuya","year":"2023","unstructured":"Furuya, H. et al. Interleukin-23 regulates inflammatory osteoclastogenesis via activation of CLEC5A+ osteoclast precursors. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.42478 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1009_CR96","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1172\/JCI134214","volume":"130","author":"D Andreev","year":"2020","unstructured":"Andreev, D. et al. Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin. J. Clin. Invest. 130, 4811\u20134830 (2020).","journal-title":"J. Clin. Invest."},{"key":"1009_CR97","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nm.3774","volume":"21","author":"K Nishikawa","year":"2015","unstructured":"Nishikawa, K. et al. DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway. Nat. Med. 21, 281\u2013287 (2015).","journal-title":"Nat. Med."},{"key":"1009_CR98","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/jbmr.1976","volume":"28","author":"Y Indo","year":"2013","unstructured":"Indo, Y. et al. Metabolic regulation of osteoclast differentiation and function. J. Bone Miner. Res. 28, 2392\u20132399 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"1009_CR99","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2017.06.018","volume":"47","author":"K Murata","year":"2017","unstructured":"Murata, K. et al. Hypoxia-sensitive COMMD1 integrates signaling and cellular metabolism in human macrophages and suppresses osteoclastogenesis. Immunity 47, 66\u201379.e65 (2017).","journal-title":"Immunity"},{"key":"1009_CR100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13072-018-0193-1","volume":"11","author":"K Kim","year":"2018","unstructured":"Kim, K., Shin, Y., Kim, J., Ulmer, T. S. & An, W. H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis. Epigenetics Chromatin 11, 23 (2018).","journal-title":"Epigenetics Chromatin"},{"key":"1009_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31475-1","volume":"13","author":"Y Xia","year":"2022","unstructured":"Xia, Y. et al. TGF\u03b2 reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis. Nat. Commun. 13, 3920 (2022).","journal-title":"Nat. Commun."},{"key":"1009_CR102","doi-asserted-by":"publisher","first-page":"115471","DOI":"10.1016\/j.bone.2020.115471","volume":"138","author":"D Kurotaki","year":"2020","unstructured":"Kurotaki, D., Yoshida, H. & Tamura, T. Epigenetic and transcriptional regulation of osteoclast differentiation. Bone 138, 115471 (2020).","journal-title":"Bone"},{"key":"1009_CR103","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1002\/jbmr.1989","volume":"28","author":"Y Kameda","year":"2013","unstructured":"Kameda, Y. et al. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase\/Akt and Erk pathways in association with signaling Adaptor DAP12. J. Bone Miner. Res. 28, 2463\u20132475 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"1009_CR104","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/eji.202149577","volume":"52","author":"S Moorlag","year":"2022","unstructured":"Moorlag, S. et al. An integrative genomics approach identifies KDM4 as a modulator of trained immunity. Eur. J. Immunol. 52, 431\u2013446 (2022).","journal-title":"Eur. J. Immunol."},{"key":"1009_CR105","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.cell.2021.03.010","volume":"184","author":"MM McDonald","year":"2021","unstructured":"McDonald, M. M. et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell 184, 1940 (2021).","journal-title":"Cell"},{"key":"1009_CR106","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","volume":"105","author":"E Tsourdi","year":"2017","unstructured":"Tsourdi, E. et al. Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone 105, 11\u201317 (2017).","journal-title":"Bone"},{"key":"1009_CR107","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.4049\/jimmunol.0803897","volume":"182","author":"JR Kiesel","year":"2009","unstructured":"Kiesel, J. R., Buchwald, Z. S. & Aurora, R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J. Immunol. 182, 5477\u20135487 (2009).","journal-title":"J. Immunol."},{"key":"1009_CR108","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","volume":"116","author":"H Li","year":"2010","unstructured":"Li, H. et al. Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood 116, 210\u2013217 (2010).","journal-title":"Blood"},{"key":"1009_CR109","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/jbmr.2868","volume":"31","author":"L Ib\u00e1\u00f1ez","year":"2016","unstructured":"Ib\u00e1\u00f1ez, L. et al. Inflammatory osteoclasts prime TNF\u03b1-producing CD4+ T cells and express CX3 CR1. J. Bone Miner. Res. 31, 1899\u20131908 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"1009_CR110","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54493","author":"MB Madel","year":"2020","unstructured":"Madel, M. B. et al. Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1. Elife https:\/\/doi.org\/10.7554\/eLife.54493 (2020).","journal-title":"Elife"},{"key":"1009_CR111","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/rheumatology\/35.11.1101","volume":"35","author":"ML Prevoo","year":"1996","unstructured":"Prevoo, M. L. et al. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br. J. Rheumatol. 35, 1101\u20131105 (1996).","journal-title":"Br. J. Rheumatol."},{"key":"1009_CR112","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1136\/annrheumdis-2016-210424","volume":"76","author":"S Alivernini","year":"2017","unstructured":"Alivernini, S. et al. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission? Ann. Rheum. Dis. 76, 1228\u20131236 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR113","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3109\/14397595.2014.987421","volume":"25","author":"N Tokai","year":"2015","unstructured":"Tokai, N. et al. Predictive value of bone destruction and duration of clinical remission for subclinical synovitis in rheumatoid arthritis patients. Mod. Rheumatol. 25, 540\u2013545 (2015).","journal-title":"Mod. Rheumatol."},{"key":"1009_CR114","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/art.24298","volume":"60","author":"N Knowlton","year":"2009","unstructured":"Knowlton, N. et al. The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states. Arthritis Rheum. 60, 892\u2013900 (2009).","journal-title":"Arthritis Rheum."},{"key":"1009_CR115","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.celrep.2014.09.032","volume":"9","author":"AV Misharin","year":"2014","unstructured":"Misharin, A. V. et al. Nonclassical Ly6C\u2212 monocytes drive the development of inflammatory arthritis in mice. Cell Rep. 9, 591\u2013604 (2014).","journal-title":"Cell Rep."},{"key":"1009_CR116","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/annrheumdis-2012-203130","volume":"73","author":"JA van Nies","year":"2014","unstructured":"van Nies, J. A. et al. What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann. Rheum. Dis. 73, 861\u2013870 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR117","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1136\/annrheumdis-2018-214746","volume":"78","author":"LJJ van Mens","year":"2019","unstructured":"van Mens, L. J. J. et al. Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate. Ann. Rheum. Dis. 78, 610\u2013616 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR118","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","volume":"400","author":"DI Krijbolder","year":"2022","unstructured":"Krijbolder, D. I. et al. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet 400, 283\u2013294 (2022).","journal-title":"Lancet"},{"key":"1009_CR119","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000079","volume":"2","author":"D Aeberli","year":"2016","unstructured":"Aeberli, D. et al. Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis. RMD Open 2, e000079 (2016).","journal-title":"RMD Open"},{"key":"1009_CR120","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2010.10.008","volume":"140","author":"AC Vos","year":"2011","unstructured":"Vos, A. C. et al. Anti-tumor necrosis factor-\u03b1 antibodies induce regulatory macrophages in an Fc region-dependent manner. Gastroenterology 140, 221\u2013230 (2011).","journal-title":"Gastroenterology"},{"key":"1009_CR121","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2011-200548","volume":"71","author":"B Saleem","year":"2012","unstructured":"Saleem, B. et al. Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study. Ann. Rheum. Dis. 71, 1316\u20131321 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR122","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/annrheumdis-2012-201593","volume":"72","author":"HH Chen","year":"2013","unstructured":"Chen, H. H. et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann. Rheum. Dis. 72, 1206\u20131211 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR123","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/art.34595","volume":"64","author":"TR Mikuls","year":"2012","unstructured":"Mikuls, T. R. et al. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum. 64, 3522\u20133530 (2012).","journal-title":"Arthritis Rheum."},{"key":"1009_CR124","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/annrheumdis-2014-206493","volume":"74","author":"ME Sandberg","year":"2015","unstructured":"Sandberg, M. E., Bengtsson, C., Klareskog, L., Alfredsson, L. & Saevarsdottir, S. Recent infections are associated with decreased risk of rheumatoid arthritis: a population-based case-control study. Ann. Rheum. Dis. 74, 904\u2013907 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1009_CR125","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","volume":"30","author":"SK Biswas","year":"2009","unstructured":"Biswas, S. K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475\u2013487 (2009).","journal-title":"Trends Immunol."},{"key":"1009_CR126","doi-asserted-by":"publisher","first-page":"108325","DOI":"10.1016\/j.celrep.2020.108325","volume":"33","author":"M Jeljeli","year":"2020","unstructured":"Jeljeli, M. et al. Macrophage immune memory controls endometriosis in mice and humans. Cell Rep. 33, 108325 (2020).","journal-title":"Cell Rep."},{"key":"1009_CR127","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1161\/ATVBAHA.114.303887","volume":"34","author":"S Bekkering","year":"2014","unstructured":"Bekkering, S. et al. Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler. Thromb. Vasc. Biol. 34, 1731\u20131738 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1009_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13436","volume":"7","author":"S Geng","year":"2016","unstructured":"Geng, S. et al. The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis. Nat. Commun. 7, 13436 (2016).","journal-title":"Nat. Commun."},{"key":"1009_CR129","doi-asserted-by":"publisher","first-page":"776879","DOI":"10.3389\/fimmu.2021.776879","volume":"12","author":"S Fuentelsaz-Romero","year":"2021","unstructured":"Fuentelsaz-Romero, S. et al. The macrophage reprogramming ability of antifolates reveals soluble CD14 as a potential biomarker for methotrexate response in rheumatoid arthritis. Front. Immunol. 12, 776879 (2021).","journal-title":"Front. Immunol."},{"key":"1009_CR130","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bmj.38261.496366.82","volume":"329","author":"J Vaugelade","year":"2004","unstructured":"Vaugelade, J., Pinchinat, S., Guiella, G., Elguero, E. & Simondon, F. Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso. Br. Med. J. 329, 1309 (2004).","journal-title":"Br. Med. J."},{"key":"1009_CR131","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis, J. et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl Acad. Sci. USA 109, 17537\u201317542 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1009_CR132","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","volume":"12","author":"J Quintin","year":"2012","unstructured":"Quintin, J. et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12, 223\u2013232 (2012).","journal-title":"Cell Host Microbe"},{"key":"1009_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13636-x","volume":"10","author":"M Jeljeli","year":"2019","unstructured":"Jeljeli, M. et al. Trained immunity modulates inflammation-induced fibrosis. Nat. Commun. 10, 5670 (2019).","journal-title":"Nat. Commun."},{"key":"1009_CR134","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.celrep.2018.09.092","volume":"25","author":"P Saz-Leal","year":"2018","unstructured":"Saz-Leal, P. et al. Targeting SHIP-1 in myeloid cells enhances trained immunity and boosts response to infection. Cell Rep. 25, 1118\u20131126 (2018).","journal-title":"Cell Rep."},{"key":"1009_CR135","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nature05836","volume":"447","author":"SL Foster","year":"2007","unstructured":"Foster, S. L., Hargreaves, D. C. & Medzhitov, R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972\u2013978 (2007).","journal-title":"Nature"},{"key":"1009_CR136","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.4049\/jimmunol.2001225","volume":"206","author":"KT Cunningham","year":"2021","unstructured":"Cunningham, K. T., Finlay, C. M. & Mills, K. H. G. Helminth imprinting of hematopoietic stem cells sustains anti-inflammatory trained innate immunity that attenuates autoimmune disease. J. Immunol. 206, 1618\u20131630 (2021).","journal-title":"J. Immunol."},{"key":"1009_CR137","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.immuni.2016.06.017","volume":"45","author":"I Martinez-Gonzalez","year":"2016","unstructured":"Martinez-Gonzalez, I. et al. Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity 45, 198\u2013208 (2016).","journal-title":"Immunity"},{"key":"1009_CR138","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41586-019-1276-2","volume":"570","author":"A Ardain","year":"2019","unstructured":"Ardain, A. et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature 570, 528\u2013532 (2019).","journal-title":"Nature"},{"key":"1009_CR139","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature24271","volume":"550","author":"S Naik","year":"2017","unstructured":"Naik, S. et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature 550, 475\u2013480 (2017).","journal-title":"Nature"},{"key":"1009_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03225","author":"A Hamada","year":"2019","unstructured":"Hamada, A., Torre, C., Drancourt, M. & Ghigo, E. Trained immunity carried by non-immune cells. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2018.03225 (2019).","journal-title":"Front. Microbiol."},{"key":"1009_CR141","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","volume":"24","author":"RJ Arts","year":"2016","unstructured":"Arts, R. J. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24, 807\u2013819 (2016).","journal-title":"Cell Metab."},{"key":"1009_CR142","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102698118","author":"E Jentho","year":"2021","unstructured":"Jentho, E. et al. Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.2102698118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1009_CR143","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1002\/art.24140","volume":"58","author":"C Ospelt","year":"2008","unstructured":"Ospelt, C. et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 58, 3684\u20133692 (2008).","journal-title":"Arthritis Rheum."},{"key":"1009_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02892-y","volume":"9","author":"F Mizoguchi","year":"2018","unstructured":"Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat. Commun. 9, 789 (2018).","journal-title":"Nat. Commun."},{"key":"1009_CR145","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard, G. & Firestein, G. S. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat. Rev. Rheumatol. 16, 316\u2013333 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1009_CR146","doi-asserted-by":"publisher","first-page":"8402","DOI":"10.1073\/pnas.1019437108","volume":"108","author":"SK Chang","year":"2011","unstructured":"Chang, S. K. et al. Cadherin-11 regulates fibroblast inflammation. Proc. Natl Acad. Sci. USA 108, 8402\u20138407 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1009_CR147","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1002\/art.30630","volume":"63","author":"EH Noss","year":"2011","unstructured":"Noss, E. H., Chang, S. K., Watts, G. F. & Brenner, M. B. Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement. Arthritis Rheum. 63, 3768\u20133778 (2011).","journal-title":"Arthritis Rheum."},{"key":"1009_CR148","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1126\/science.1137306","volume":"315","author":"DM Lee","year":"2007","unstructured":"Lee, D. M. et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 315, 1006\u20131010 (2007).","journal-title":"Science"},{"key":"1009_CR149","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/art.37853","volume":"65","author":"A Lee","year":"2013","unstructured":"Lee, A. et al. Tumor necrosis factor \u03b1 induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 65, 928\u2013938 (2013).","journal-title":"Arthritis Rheum."},{"key":"1009_CR150","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/art.38871","volume":"67","author":"C Sohn","year":"2015","unstructured":"Sohn, C. et al. Prolonged tumor necrosis factor \u03b1 primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheumatol. 67, 86\u201395 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1009_CR151","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00281-017-0621-5","volume":"39","author":"C Ospelt","year":"2017","unstructured":"Ospelt, C., Gay, S. & Klein, K. Epigenetics in the pathogenesis of RA. Semin. Immunopathol. 39, 409\u2013419 (2017).","journal-title":"Semin. Immunopathol."},{"key":"1009_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04310-9","volume":"9","author":"R Ai","year":"2018","unstructured":"Ai, R. et al. Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes. Nat. Commun. 9, 1921 (2018).","journal-title":"Nat. Commun."},{"key":"1009_CR153","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-022-01285-0","volume":"23","author":"M Yan","year":"2022","unstructured":"Yan, M. et al. ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts. Nat. Immunol. 23, 1330\u20131341 (2022).","journal-title":"Nat. Immunol."},{"key":"1009_CR154","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","volume":"54","author":"J Fri\u0161\u010di\u0107","year":"2021","unstructured":"Fri\u0161\u010di\u0107, J. et al. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity 54, 1002\u20131021.e1010 (2021).","journal-title":"Immunity"},{"key":"1009_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98651-z","volume":"11","author":"K Koedderitzsch","year":"2021","unstructured":"Koedderitzsch, K., Zezina, E., Li, L., Herrmann, M. & Biesemann, N. TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A. Sci. Rep. 11, 19385 (2021).","journal-title":"Sci. Rep."},{"key":"1009_CR156","doi-asserted-by":"publisher","DOI":"10.1002\/art.42378","author":"J Fri\u0161\u010di\u0107","year":"2022","unstructured":"Fri\u0161\u010di\u0107, J. et al. Reset of inflammatory priming of joint tissue and reduction of the severity of arthritis flares by bromodomain inhibition. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.42378 (2022).","journal-title":"Arthritis Rheumatol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01009-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01009-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01009-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T09:02:30Z","timestamp":1695373350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01009-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":156,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1038\/s41584-023-01009-0","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"21 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.E.A. declares that he has received speaker fees, research support and\/or served on advisory boards for Novartis, Pfizer and Merck. M.M.J. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}